Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bielsa

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Investigational Allergology & Clinical Immunology|February 14, 2025
Predictive Factors and Optimization of Omalizumab in Chronic Spontaneous Urticaria: A Multicenter Study of 257 PatientsJ Ceravalls, A M Giménez-Arnau, V Expósito-Serrano, et al.
The British Journal of Dermatology|January 26, 2018
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticariaL Curto-Barredo, J Spertino, I Figueras-Nart, et al.
Actas Dermo-Sifiliograficas|December 23, 2015
Core Content for Undergraduate Medical Education in Spain: Recommendations of the Instructors' Group of the Spanish Academy of Dermatology and Venereology (AEDV)J M Casanova, R M Pujol, C Ferrándiz, et al.
Actas Dermo-Sifiliograficas|August 16, 2018
Algorithm for Treatment of Chronic Spontaneous Urticaria with OmalizumabJ Spertino, L Curto Barredo, E Rozas Muñoz, et al.
Actas Dermo-Sifiliograficas|February 23, 2024
Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous LymphomasR Izu-Belloso, I Gainza-Apraiz, P Ortiz-Romero, et al.
Actas Dermo-Sifiliograficas|April 23, 2018
The First Year of the AEVD Primary Cutaneous Lymphoma RegistryY Peñate, O Servitje, S Machan, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Investigational Allergology & Clinical Immunology|February 14, 2025
Predictive Factors and Optimization of Omalizumab in Chronic Spontaneous Urticaria: A Multicenter Study of 257 PatientsJ Ceravalls, A M Giménez-Arnau, V Expósito-Serrano, et al.
The British Journal of Dermatology|January 26, 2018
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticariaL Curto-Barredo, J Spertino, I Figueras-Nart, et al.
Actas Dermo-Sifiliograficas|December 23, 2015
Core Content for Undergraduate Medical Education in Spain: Recommendations of the Instructors' Group of the Spanish Academy of Dermatology and Venereology (AEDV)J M Casanova, R M Pujol, C Ferrándiz, et al.
Actas Dermo-Sifiliograficas|August 16, 2018
Algorithm for Treatment of Chronic Spontaneous Urticaria with OmalizumabJ Spertino, L Curto Barredo, E Rozas Muñoz, et al.
Actas Dermo-Sifiliograficas|February 23, 2024
Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous LymphomasR Izu-Belloso, I Gainza-Apraiz, P Ortiz-Romero, et al.
Actas Dermo-Sifiliograficas|April 23, 2018
The First Year of the AEVD Primary Cutaneous Lymphoma RegistryY Peñate, O Servitje, S Machan, et al.
Pageof 7